Equity: Global Pharma, Biotech & Life Sciences ETFs (segment)
This page lists all 6 US-listed ETFs in the Equity: Global Pharma, Biotech & Life Sciences segment with combined assets of $260.60M. Returns are aggregated using AUM-weighting where applicable.
Category Returns (AUM-Weighted)
| Period | AUM-Weighted | Simple Avg |
|---|---|---|
| 1 Day | -1.10% | -0.81% |
| 1 Week | -3.65% | -3.00% |
| 1 Month | -2.54% | -2.84% |
| 3 Months | 1.12% | 1.71% |
| 6 Months | 1.06% | -6.78% |
| YTD | 3.52% | -2.04% |
| 1 Year | 36.24% | 15.42% |
| 3 Years | -35.45% | -16.47% |
| 5 Years | — | — |
| 10 Years | — | — |
Top Equity: Global Pharma, Biotech & Life Sciences ETFs by AUM
| Symbol | Fund Name | AUM | Expense Ratio |
|---|---|---|---|
| CANC | Tema Oncology ETF | $168.41M | 0.01% |
| HRTS | Tema Heart & Health ETF | $52.15M | 0.01% |
| PSIL | AdvisorShares Psychedelics ETF | $34.88M | 0.01% |
| IBRN | iShares Neuroscience and Healthcare ETF | $5.16M | 0.00% |
| CNCR | Range Cancer Therapeutics ETF | — | 0.01% |
| MNTL | Tema Neuroscience and Mental Health ETF | — | 0.01% |